Rules 2008
PLEASE READ CAREFULLY
This futurity is run under NSBA rules, unless the Dakota 50/50 Sale and Futurity rules read otherwise:
GOALS OF THE BREEDERS ORGANIZATION
Purpose – to train and develop all horses
in a humane manner, protecting at all times, their physical and mental
personalities.
1. To promote a good moving, well broke
individual whose conformation is correct and sound, and with eye appeal.
HORSES THAT RIDE, WORK, AND LOOK GOOD DOING IT
2. To promote a variety of breeds
through their participation in the Sale & Futurity.
3. Provide an event that is enjoyable to
the spectator.
4. Provide an event that is beneficial
to the Dakota Horse Industry.
Summary: To promote kinder training
methods, resulting in a more efficient horse and to establish a greater market
for good riding horses – horses that have soft mouths, respond to a light rein
and have a comfortable head carriage.
SALE EXPLANATION
The 2006 Dakota 50/50 Sale and Futurity will be held at the North Dakota Horse Park, 5180 19th Ave. North, Fargo, ND, 58102.
All weanlings selling in the sale will be
eligible to compete in the Dakota 50/50 Futurity at 2 years of age.
50% of the selling price of the weanlings
sold in the 50/50 Sale will be retained by the Dakota 50/50 Sale and Futurity and used as operating expenses, purse,
& member/consignor awards in the 50/50 Futurity.
50% of the selling price goes to the
“MEMBER/CONSIGNOR”
40% of the selling price goes to the
“FUTURITY PURSE”
5% of the selling price goes to the
“MEMBER/CONSIGNOR AWARDS”
5% of the selling price goes to the
Operating Expenses.
FUTURITY EXPLANATION
The Dakota 50/50 Futurity is designed to
promote quality horses. There will be one event consisting of three (3) equal
parts or divisions in which points are totaled to achieve a winner.
1. CONFORMATION
DIVISION – Emphasis is
to be placed on an individual that is
conformationally correct and sound on all feet and legs. That is a balanced,
smooth individual
whose parts all blend together with eye appeal and the
appearance of an
athletic individual.
2. RAIL DIVISION –
designed to show a free and easy moving individual that is
relaxed, ears alert, looks balanced and his way of
going forward is bright as well as responsive to the rider at various gaits.
When asked to extend the jog, or may be asked to extend the lope, he moves out
with the same smooth natural way of going. Rail work consists of the walk, jog
and lope with the extension of the jog and possibly the lope, in either
direction of the ring to be shown on a loose rein or light contact without
undue restraint. Judging will be based on the horses’ overall performance and
way of going, as well as its ability to hold the designated gait and correct
leads. Rail division may be divided at the discretion of the show committee
based on the size of the arena and the number of entrants. Sections will be
determined by random draw.
3. PATTERN
DIVISION – will consist of
an individual pattern of work, designed to
show how well broke the horse is. Emphasis is to be
placed on the execution of the pattern with regard to the correctness of the
maneuver and overall smoothness of the pattern. Horses will be asked to
demonstrate leads and lead departures, circles, simple lead changes, soft stops,
back and turn on the haunches. Maneuvers to be judged at the two year old
level.
GENERAL SCORING RULES
1. Futurity will consist of two
go-rounds, evaluated by two judges in each round, total of
four judges.
2. All judges’ scores will be used.
3. The winner of the Futurity will be
the horse receiving the most points overall from the
three divisions
in the two go-rounds.
4. Horses placing in the top ten in each
class will be given one point plus an additional
point for each horse placing below him, not to
exceed 10 points for first place. Points are calculated through ten placings
only.
EXAMPLE – If 10
in class – 1st place horse gets 10 points, 2nd place
horse
– 9 points, etc. In a class of 7 horses
– 1st place horse gets 7 points, 2nd place horse gets 6
points and so on.
5. In the case of any ties, points will
be equally split.
6. All horses
must complete all divisions, both days, in order to be eligible for the purse. Excusing
a horse from the arena prior to completion of the class or pattern, whether by
judge, show committee or rider, will disqualify the horse from any and all
awards.
7. All entries will remain in the
designated area during the entire go round. Tack and equipment changes will be
made in the arena. Due to space constraints entrants may be asked to rotate to
a designated area. The same contestants must exhibit or compete in both
go-rounds and all divisions. One horse, one rider. Futurity order of
divisions will be the same for both go-rounds: Conformation, Rail and Pattern.
Scoring guide:
The pattern class will be judged using scribes to mark the scores. Maneuvers to score from 0-10.
Poor 0 - 2 ½ ; Fair 2 ½ - 5; Good 5 - 7
½; Excellent 7 ½ - 10.
Penalties to be given for the following:
5 point penalty – refusal, bucking,
kicking, rearing
10-point penalty – blatant disobedience,
going off pattern
Dismissal – excessive abuse, horse or
rider falling to the ground
Conduct
Conduct on show grounds of members and
non-members, exhibitors, trainers, owners, and their representatives, together
with all other persons being present on show grounds such as spectators, shall
be orderly responsible, sportsmanlike and humane in the treatment of horses
such as to promote the implementation of the show and promote fair, competition.
Unsportsmanlike or irresponsible conduct or any other form of misconduct, such
as illegal, indecent, or profane, and the inhumane treatment of horses is
prohibited. Show management may immediately expel offenders from show grounds
and/or disqualify exhibitors and their horses in order to preserve the decorum
of the show and shall file a written report with the Dakota 50/50 concerning
the transaction.
Equipment
1. All horses are to be shown in
standard headstall (brow band, shaped or split ear).
2. All horses to be shown in Western
Equipment and attire.
3. All horses are to be shown in a bosal
or snaffle bit that meets NSBA Rules. 5/16” bit
measurement with
a ring size of not less than 2 inches and no more than 4 inches.
4. All equipment and bits will be
checked by an equipment judge.
5. Training
devices (anything other than the legal snaffle-bit or bosal as stated in
the
above Rule #3) are prohibited in the show arena and designated warm-up arena at
all times.
6. All tack changes will be made in the
arena with the assistance of not more than two
helpers.
7. Split or tied reins may be used,
however all horses are to be shown with both hands on
the reins.
8. Horses with false or deadened tails,
or illegal or inhumane equipment in the show
arena will be eliminated from competition. Hair to hair extensions are not permitted in the Dakota 50/50 Futurity. Every
horse in the 50/50 futurity must have a natural tail function. Any horse
believed not to have a natural tail function will be inspected by the attending
veterinarian. If it is determined that the horse does not have a natural tail
function it will be excluded from the 50/50 futurity competition.
9. Horses and equipment are subject to
examination by the Steward, Show Management
and/or Judges in
the show arena and designated warm-up arenas at all times.
ILLEGAL PRACTICES
-
All horses entered in Dakota 50/50 events
are subject to drug testing. Drug testing of the horses entered in Dakota
50/50 approved events will be conducted by a licensed veterinarian(s),
approved by the Dakota 50/50, at the request of show management or Dakota
50/50. Said veterinarian(s) may appoint a technician(s) to perform certain
duties under this article.
-
A veterinary station will be set aside
for the collection of samples.
-
Each owner, exhibitor, trainer and agent
is responsible for compliance with these rules.
-
No person shall cause to be administered
internally or externally, to a horse, either before or during an approved
event, any medication, drug, mechanical device or artificial appliance
which is of such character as could affect its performance or appearance
at that event, EXCEPT FOR THOSE CONDITIONALLY PERMITTED THERAPEUTIC
MEDICATIONS, THE USE OF WHICH IS SPECIFICALLY PROVIDED FOR IN THE THERAPEUTIC
MEDICATION SUBSECTION OF THIS RULE AND NOT OTHERWISE PROHIBITED BY GOVERNMENTAL REGULATIONS. Upon
discovery of administration of such drug, medication, mechanical device or
artificial appliance, show management shall immediately report the matter
to the Dakota 50/50. Any action or substance administered internally or
externally, whether drugs or otherwise, which may interfere with the
testing procedure and/or detection of any foreign substance to mask or
screen the presence of such drug, is forbidden.
-
-
Presence of such medication or drug in a
horse participating in a Dakota 50/50-approved event shall be grounds for
the Executive Committee or other appropriate committee to disqualify the
horse if it is determined that the use of said drug or medication was not
within the guidelines set in the Therapeutic Medication section of this
rule.
-
It is presumed that the sample of urine,
saliva, blood or other substance tested by the approved laboratory to
which it is sent is the one taken from the horse in question, and its
integrity is preserved. All procedure of such collection and
preservation, transfer to the laboratory, and analysis of the sample are
correct and accurate, and that the report received from the laboratory
pertains to the sample taken from the horse in question. It correctly
reflects the condition of the horse during the event in which he/she was
entered, with the burden on the exhibitor or other responsible party to
prove otherwise at any hearing in regard to the matter, conducted by the
Dakota 50/50.
-
Presence of such medication or drug in a
horse participating in a Dakota 50/50-approved event shall be grounds for
the appropriate committee of the Association to take the following
action: The horse and the individual(s) responsible for the condition of
the horse shall forfeit any points, prizes and/or earnings earned at the
Dakota 50/50 event.
The
above-specified individuals are absolutely responsible for a horse’s condition,
and are presumed to know all rules and regulations of the Association and the
penalty provisions of said rules. Their voluntary action in presenting or
causing the horse to be presented at show grounds for exhibition, entering a
horse or exhibiting one in an approved event, and their absolute responsibility
for the condition of the horse, may make them eligible for disciplinary
sanctions, whether or not they had actual knowledge of the presence of a
forbidden drug, directly participated in the administration thereof, innocently
miscalculated its retention time in the horse’s system, or for any other reason
that its presence is established.
An individual is
absolutely responsible for a horse’s condition if:
1) She/he designates him/herself on the entry blank
as exhibitor, or authorizes another to designate him/her as exhibitor on the entry
blank;
2) She/he signs the entry blank on behalf of
him/herself or another, or causes an agent or representative to sign it;
3) She/he physically participates in the event in
riding or showing the horse; or
4) She/he is the actual trainer, having presented
or caused to be presented the horse at the show grounds for exhibition. Both
the exhibitor designated on the entry blank and one having actual possession of
the horse while physically participating with the horse in the event are
conclusively presumed to be authorized by the owner to execute all documents,
necessary or convenient, to allow the horse’s participation in a Dakota
50/50-approved event, including documents pertaining to drug testing and use of
Lasix. If an individual is prevented from performing his/her duties, including
absolute responsibility for the condition of the horse, by illness or
otherwise, or is absent from the show, he/she shall immediately notify the show
secretary and, at the same time, appoint a substitute. Such substitute shall
place his/her name on the entry blank forthwith. The exhibitor and owner
acknowledge an exhibitor represents the owner in regard to his/her horses
entered in an approved show.
-
The trainer/exhibitor or his/her
representative, must be present when the saliva, urine, or other specimen
is taken from his/her horse, and must remain until the specimen is sealed
and the official form signed by him, or his representative, as witness to
the taking of the specimen.
-
Every exhibitor shall, upon request of
show management or representative or Dakota 50/50 representative, permit
a specimen of urine, saliva, blood or other substance to be taken for
testing. Refusal to comply with such request shall constitute grounds for
immediate disqualification of the horse. If the laboratory report on the
chemical analysis of saliva, urine, blood or other substance taken from
the horse indicates the presence of a forbidden drug or medication, this
shall be taken as prima facie evidence that such substance has been
administered to the horse either internally or externally. Failure on the
part of the owner, trainer/representative/exhibitor, to be present at, or
refusal to allow the taking of any specimen, or any act or threat to
prevent or otherwise interfere therewith, shall be cause for disqualification
of the horse involved.
THERAPEUTIC MEDICATIONS (Does not
apply if prohibited by governmental regulations)
-
EXHIBITORS, OWNERS, TRAINERS AND VETERINARIANS ARE CAUTIONED AGAINST THE USE OF
MEDICINAL PREPARATIONS, TONICS, PASTES AND PRODUCTS OF ANY KIND, THE INGREDIENTS AND QUANTITATIVE ANALYSIS OF WHICH ARE NOT SPECIFICALLY KNOWN. MANY OF
THEM MAY CONTAIN A
FORBIDDEN SUBSTANCE.
i. Forbidden Drugs or substances:
1. Any drug or substance considered a Class 1 or
Class II substance as defined in the ARCI’s Uniform Classification guidelines for Foreign Substances, Revised Edition, February 14, 1995.
2. Any stimulant, depressant, tranquilizer or
sedative, which could affect the performance of a horse (stimulants and
depressants are defines as substances which stimulate or depress the
cardiovascular, respiratory or central nervous systems.)
3. Any substance, regardless of how harmless or
innocuous it might be, which might interfere with the detection or quantitation
of any substance defined in (1), (2) or (3).
ii. Conditionally permitted therapeutic medication
1. Any drug, medication or substance, which could
affect the performance of a horse that is used for the legitimate treatment of
illness or injury and is not specified as a forbidden substance as defined in
paragraph i(1) above.
HOWEVER, THESE
DRUGS OR SUBSTANCES ARE FORBIDDEN AND USE THEREOF
SUBJECTS THE PERSON TO DISCIPLINARY ACTION, UNLESS ALL CONDITIONS OF THEIR ADMINISTRATION ARE MET.
Each of the
following requirements is a condition to authorize administration of
conditionally permitted therapeutic medications, which shall be verified in a
written medication report, in a form acceptable to the Dakota 50/50 and
available from Dakota 50/50 show management. It will be completed in its’
entirety, and filed with show management before exhibition of the horse (See
3-11).
2. Administration by a veterinarian who is licensed
to practice veterinary medicine in the state where the event is being held or
from a written prescription (written instruction) by a licensed veterinarian,
which documents administration of medication necessary for the treatment of
illness or injury. The administration of a conditionally permitted therapeutic
medication for the purpose of transport, grooming, training, etc. is not
therapeutic under this authorization rule.
3. The horse must be withdrawn and kept out of
competition for not less than 24 hours after the medication is administered.
4. Identification of the medication: (name, amount,
strength, and mode of administration.)
5. Date and time of administration.
6. Identification of the horse: name, age, color,
sex and entry number.
7. Diagnosis of illness/injury, reason for
administration, and name of administering and/or prescribing veterinarian.
8. Signature of veterinarian or person
administering the medication. If by prescription (written instructions) a copy
must be attached to medication report.
9. The medication report form must be filed with
show management within one hour after administration of the medication or one
hour after show management is available, if administration occurs at a time
other than during competition hours.
10. While this report must be filed only if the administered medication
will be present in amounts detectable in blood and/or urine samples at the time
of competition/sampling, exhibitors are hereby cautioned that it is their
responsibility to determine whether or not such medication has had time to
clear the horses’ system. IF THERE IS ANY DOUBT, A MEDICATION REPORT SHOULD BE
FILED.
iii. Restrictions concerning use of a conditionally
permitted medications that may be administered within 24 hours of showing:
1. Only the ten (10) drugs or medications listed
below may be administered within 24 hours of showing and should be administered
in accordance with the recommendation following each to best assure compliance
with maximum allowable plasma levels.
a. Phenylbutazone – The maximum permitted plasma
concentration of phenylbutazone is 15.0 micrograms per milliliter, and the
maximum permitted trace level is 2.0 micrograms per milliliter. When
phenylbutazone is administered, the dose should be accurately calculated
according to the actual weight of the animal. Each 24 hours, not more than 2.0
milligrams per pound of body weight should be administered. For a 1000-pound
animal, the maximum daily dose is 2.0 grams, which equals two 1.0-gram tablets,
or two 1.0 gram units of paste, or 10.0 cc of the injectable (200 milligrams
per milliliter). No part of a dose should be administered during the twelve
(12) hours prior to competing. If the medication is administered in the feed,
the medicated feed must be consumed and/or removed at least twelve (12) hours
prior to competing. The medication should not be used for more than five
consecutive days.
b. Flunixin – The maximum permitted plasma
concentration of Flunixin is 1.0 microgram per milliliter, and the maximum
permitted trace level is 0.2 micrograms per milliliter. When Flunixin Meglumine
(Banamine) is administered, the dose should be accurately calculated according
to the actual weight of the animal. Each 24 hours, not more than 0.5 milligrams
per pound of body weight should be administered. For a 1000-pound animal, the
maximum daily dose is 500 milligrams, which equals two 250 milligram packets of
granules, or one 500 milligram packet of granules, or 500 milligrams of the oral
paste (available in 1500 milligram dose syringes), or 10.0 cc of the injectable
(50 milligrams per milliliter). No part of a dose should be administered during
the twelve (12) hours prior to competing. Any medicated feed must be consumed
and/or removed at least twelve (12) hours prior to competing. The mediation
should not be use for more than five successive days.
c. Ketoprofen - The maximum permitted plasma concentration
of ketoprofen is 40.0 nanograms per milliliter, and the maximum permitted trace
level is 10.0 nanograms per milliliter. When Ketoprofen (Ketofen) is
administered, the dose should be accurately calculated according to the actual
weight of the animal. Each 24 hours, not more than 1.0 milligram per pound of
body weight should be administered. For a1000 pound animal, the maximum daily
dose is 1.0 gram, which equals 10.0 cc of the injectable (100 milligrams per
milliliter). No part of a dose should be administered during the twelve (12)hours
prior to competing. The medication should not be used more than five successive
days.
d. Meclofenamic Acid - The maximum permitted plasma concentration of
Meclofenamic Acid (Arquel) is 1.0 micrograms per milliliter, and the maximum
permitted trace level is 0.1 micrograms per milliliter. When Meclofenamic Acid
is administered, the dose should be accurately calculated according to the
actual weight of the animal. Each 24 hours, not more than 1.0 milligram per
pound of bodyweight should be administered. For a 1000-pound animal, the
maximum daily dose is 1.0 gram, which equals two 500 milligram packets of
granules. No part of a dose should be administered during the twelve (12) hours
prior to competing. Any medicated feed should be consumed and/or removed at
least twelve (12) hours prior to competing. The medication should not be used
for more than five successive days.
e. Naproxen - The maximum permitted plasma concentration
of Naproxen is 40.0 micrograms per milliliter, and the maximum permitted trace
level is 2.0 micrograms per milliliter. When Naproxen is administered, the dose
should be accurately calculated according to the actual weight of the animal.
Each 24 hours, not more than 4.0 milligrams per pound of body weight should be
administered. For a 1000-pound animal, the maximum daily dose is 4.0 grams,
which equals eight (8) 500 milligram tablets. No part of a dose should be
administered during the twelve (12) hours prior to competing. Any medicated
feed should be consumed and/or removed at least twelve (12) hours prior to
competing. The medication should not be used for more than five successive
days.
f. Acetazolamide - may only be administered to horses
documented through DNA testing to be positive (N/H or H/H) for HYPP
(Hyperkalemic Periodic Paralysis). When Acetazolamide is administered, the dose
should be accurately calculated according to the actual weight of the animal.
Each 24 hours, not more than 3 milligrams per pound of body weight should be
administered. For a 1000-pound animal, the maximum daily dose is 3 grams.
g. Furosemide or Lasix - when used, must be administered
intravenously at least 4 hours prior to competition.
h. Lidocaine/Mepivicaine - when administered within 24 hours of
showing, may only be used under actual observation of event management (or
their designated representative) and/or the official show veterinarian, either
of which must sign the medication report form, to aid in the surgical repair of
minor skin lacerations, which, by their very nature, would not prevent the
horse from competing following surgery. Medication report form must be filed with
show management as required in Section 2 above.
i. Isoxsuprine - when administered, the dose should be
accurately calculated according to the actual weight of the animal. Each 24
hours, not more than 1.6 milligrams per pound of body weight should be administered
(usually divided in two equal doses given 12 hours apart.) For a 1000-pound
animal, the maximum daily dose is 1600 milligrams, which equals eighty (80)
twenty (20) milligram tablets. No part of a dose should be administered during
the four (4) hours prior to competing. Any medicated feed should be consumed
and/or removed at least four (4) hours prior to competing.
j. Diclofenac (Surpass) - The maximum permitted plasma concentration
of Diclafenac is 0.005 micrograms per milliliter. Every 12 hours, not more than
73 mg of diclofenac liposomal cream should be administered (not more than 146
mg per 24 hour period) to one affected site. This 73 mg dose equals a 5-inch
ribbon of cream not greater than 1/2 inch in width, which should be rubbed
thoroughly into the hair over the joint or affected site using gloved hands.
Administration of diclofenac cream should be discontinued 12 hours prior to
competing. Do not apply diclofenac cream in combination with any other topical
preparations including DMSO, nitrofurazone, or liniments and do not use on an
open wound. Diclofenac cream should not be administered for more than 10
successive days.
2. If more than one
non-steroidal anti-inflammatory drug substance (NSAID) is present in the same
plasma or urine sample, no more than one is to be present in a concentration
which exceeds trace levels.
3. If two of the
non-steroidal anti-inflammatory drugs listed above are administered at any time
during the seven days prior to competing, one of them should not be
administered during the 48 hours prior to competing, in order to avoid
exceeding the maximum permitted trace level when two are present in the plasma.
4. If any third non-steroidal
anti-inflammatory drug is administered, it should not be administered during
the seven days prior to competing. (Exception:) Dipyrone, a "masking"
substance, is not to be administered during the 24 hours prior to competing. In
the event a non-steroidal anti-inflammatory drug is administered in a manner
that might cause the plasma concentration to exceed the quantitative
restrictions of the rule (in the case of those permitted to be used) or might
cause the drug to be detected at any level in plasma or urine (in the case of
those not permitted to be used) the trainer and owner should withdraw the horse
from competition. The animal should be withheld from competition until the
plasma concentration of any permitted drug returns to acceptable levels and/or
until any nonsteroidal anti-inflammatory drug not permitted by the rules is no
longer present in the blood or urine. In the event Dipyrone is administered to
a horse, the trainer and owner must comply with all of the requirements of
section (ii) of this addendum.
5. Each of the ten (10)
medications allowed in section (1) above must be administered in accordance with
the recommendations as given for each. Should the testing laboratory report the
presence of one of these drugs in an amount greater than that which would be
consistent with the recommendations or at a level higher than the maximum
permitted plasma concentration for those listed in section 3(A)(1-3), the
matter will be reviewed and disciplinary action may be taken.
6. Burden of persuasion to
establish correct dosage and time limitation rests with the responsible person.
a. Additionally, as drugs or
substances described in subparagraphs (i)(2) and (3) above, in order to avoid
disqualification by detection of a presence in the horses’ system, the
medication must be administered or prescribed (letter of instruction) by a
veterinarian, for the legitimate treatment of illness or injury, and
administered at least 24 hours before exhibition. Should the testing laboratory
report the presence of these drugs in an amount greater than that which would
be consistent with the specified dosage and/or time constraint or dosage for
legitimate treatment of illness or injury, the laboratory test result will be
reviewed and disciplinary action may be taken.
b. Laboratory detection of an
excessive dosage of an otherwise conditionally permitted therapeutic drug or
drugs specified in subparagraphs (1)(B) and (C) above shall constitute
presumption of a violation of this rule, and the responsible party has the
burden of persuasion to establish that the dosage was administered within rule
specifications.
c. To avoid this rule
violation presumption and the stringent responsibilities of this rule, the
responsible party may decide to simply withdraw the horse.
d. The above guidelines are
not considered as authorization administration of medication to any horse in
any quantity and shall not be deemed to modify this rule in any manner
regarding maximum allowable concentrations. These guidelines do not guarantee
compliance with this rule but are offered to assist responsible parties in
complying with the requirements of this rule. Responsible parties are
advised to consult a knowledgeable veterinarian. Reliance upon these guidelines
will not serve as a defense to a charge of violation of Dakota 50/50 rules
regarding administration of forbidden substance.
iv. Not withstanding the
general prohibition of this rule against artificial appliances, the use of a
pacemaker or prosthetic eye may be permitted if the owner files written request
for permission and submits documentation as requested. Request will then be
submitted to Dakota 50/50’s Executive Committee for consideration, after which,
if the request is approved, such authorization will be noted on the horse’s
show record at the Dakota 50/50 Office.
INHUMANE TREATMENT
1. Every horse
at a Dakota 50/50 approved event shall, at all times, be treated humanely and
with dignity, respect and compassion. Abuse is defined as an action, or failure
to act, which a reasonable, prudent person, informed and experienced in the
customs, accepted training techniques and exhibition procedures, or veterinary
standards would determine to be cruel, abusive, inhumane or detrimental to the
horses’ health. Individuals will be disciplined if it is determined that there
was willful abuse of the horse under any of the following circumstances:
- The individual physically participates in the abuse of the animal
or shows or rides the horse in a condition considered to be abusive.
- No persons shall exhibit any horse, which
appears sullen, dull, lethargic, emaciated, drawn or overly tired.
- No person on show
grounds, including but not limited to, barns, stalls, practice area
and show arena, may treat a horse in an inhumane manner, which
includes, but is not limited to:
- Placing an object in a horse's
mouth so as to cause undue discomfort or distress;
- Tying a horse in a manner as to
cause undue discomfort or distress in a stall, trailer or
when longeing or riding;
- Use of inhumane training
techniques or methods;
- Use of inhumane
equipment, including, but not limited to, saw tooth bits, hock
hobbles, tack collars or tack hackamores;
- Any item or appliance
that restricts movement or circulation of the tail;
- Intentional inhumane
treatment which results in bleeding.
2. Penalties for a violation of the abuse rules
are as follows:
- First offense: Disqualification.
- If a pattern of abuse is identified by an appropriate committee,
the Dakota 50/50 retains the right to ban the owner, exhibitor or responsible
party from participation in future events.
EXHIBITORS
Exhibitors may be changed after the entry
has been submitted as long as the Futurity Management is informed of the
change. However, the horse must be shown in all divisions by the same
exhibitor.
OWNERSHIP
Should any horse change ownership after
the 50/50 weanling Sale but before the Futurity, that horse
retains its' eligibility for the Futurity if, AND ONLY IF, the Futurity Management has been notified by said
horses’ current owner. The current owner must provide notification of
ownership to the management. All monies will go to the current owner of the
entry.
PROTEST
A protest must be made IN WRITING to
the President within 6 hours of the time of the issue of the protest. No
protest will be entertained unless it is accompanied by a deposit of $200.00
cash, which shall be forfeited if protest is not sustained.
FEES AND GUARANTEES
Horses properly entered are considered
paid up into the Futurity with the exception of a $150.00 which includes the
office, stall, judges and drug test fees payable by August 1st, 2008. A $50.00 late fee will be charged on
entries received after August
1, 2008.
ALL CHEQUES TO BE MADE PAYABLE TO THE
DAKOTA 50/50 FUTURITY AND SALE.
PRIZE MONEY
1. All prize money and awards will be distributed by mail or
delivery when drug test results have cleared, or at discretion of the show
committee.
2. Anyone willing $600 or greater must
provide their Social Security # to the 50/50 for tax purposes, prior to receipt
of payment. A space will be provided on the entry form.
3. Top 10 horses will be escorted from
the arena by members of the show committee to the veterinary station for drug
testing by blood draw.
4. Prize money will be paid to the top
ten in the Futurity
5. Money will be split in case of a tie.
6. Any ties for awards will be broken by
the judge.
7. Member/Consignor award prize money to
be paid to the Breeders of the 1st, 2nd, and 3rd place horses.
8. All Futurity
entries to remain in arena following the show. Presentations and pictures will take place in main arena
immediately following the show.
| Prize money distribution: |
| Purse 2008: |
Breeders
Incentive: |
| 1st 28% |
3799.60 |
1st |
50% 848.12 |
| 2nd 17% |
2306.90 |
2nd |
30% 508.88 |
| 3rd 14% |
1899.80 |
3rd |
20% 339.25 |
| 4th 11% |
1492.70 |
Total |
$1696.25 |
| 5th 9% |
1221.30 |
|
|
| 6th 7% |
949.90 |
|
|
| 7th 5% |
678.50 |
|
|
| 8th 4% |
542.80 |
|
|
| 9th 3% |
407.10 |
|
|
| 10th 2% |
271.40 |
|
|
| Total |
$13,570.00 |
|
|
| |
|
|
|
These are unofficial award totals and must
be confirmed by the Dakota 50/50 Treasurer.
Other awards or incentives may be presented
for individual divisions or other basis. Funding for these awards will be from
other sponsorship and will not affect the cash purse.
Additional Awards
Amateur
Award: A trophy Saddle to be presented to top amateur rider, regardless of placing in the overall
futurity; sponsored by Gustafson Oil, Rolla, ND. To be eligible for the amateur award the rider must
be riding a horse they own, or owned by an immediate family member and must
carry an amateur card from their appropriate breed association.
Youth Award: A trophy Buckle will be presented
to top youth rider (18 years of age or younger by January 1, 2008); sponsored
by Alkali Ranch, Deloraine, Manitoba and Clay Ranch, Cartwright, Manitoba.
Non-Youth,
Non Amateur Rider: A
show Halter will be presented to the top rider not entered in the
Amateur or Youth divisions; sponsored by BCMG Ranch, St. John, ND.
Division
Awards: Top horse in
each division will be presented with award.
Sportsmanship
Award: An award will
be presented to the person displaying the best sportsmanship throughout the
futurity as voted on by their peers.
RIGHTS RESERVED BY THE 50/50 FUTURITY
MANAGEMENT AND BOARD OF DIRECTORS OF THE DAKOTA 50/50 SALE AND FUTURITY.
Management Reserves the right to:
1. Reject any entry not believed to
match the sale entry.
2. Inspect all horses and match them to
the registration papers on file from the weanling sale.
3. Decide any point not covered by the
rules and to correct any errors or make any necessary alterations as it sees
fit.
4. Change date and locations of the
Dakota 50/50 Sale and Futurity.
5. Test any Futurity entry for illegal or controlled substance,
according to Dakota 50/50 rules. See section on illegal practices, p. 5.
6. Hold another 50/50 Sale (Spring) of yearlings and 2 year olds making them
eligible for the Futurity.
FOR ADDITIONAL INFORMATION CONTACT:
Nikki Medalen
7049 Willow Road
Towner, ND 58788
701-537-5548
nikki@medalenranch.com
Officers for 2004:
President: Darrel
Gustufson 701-477-5434
Vice President: Nikki Medalen 701-537-5548
Treasurer: Stephanie
Bennis 701-624-5193
Secretary: Vonda
Horner 701-223-7201
|